BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Getting breast implants was a mistake I live with every day. Why I’m sharing my story now, at 70, in pain and afraid. - 2Jupiter and the moon take a sunset stroll on March 26. Here's how to see it
- 3'Outrageous and illegal' : UNRWA slams Israel for cutting off its water, comms and electric in Gaza
- 43 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 2025
- 5Surprise! Saturn's huge moon Titan may not have a buried ocean after all
- HGV driver recruited others to smuggle migrants
- What you need to know about desalination, a growing source of drinking water
- The most effective method to Pick The Right Speakers
- I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next
- Figure out How to Plan for Your Web-based Degree monetarily
- Is an $85 apple pie worth it? Our Thanksgiving taste test says … maybe.
- Practice environmental safety in Style: Divulging Famous Electric Vehicle Brands
- Flu activity rises sharply across US with 7.5 million cases, CDC data shows
- Top notch DSLR Cameras for Photography Devotees
